Metoprolol Aurobindo (Metoprolol Tartrate)

Metoprolol Aurobindo is a beta‑blocker indicated for several cardiovascular conditions.

• Hypertension: reduces systolic and diastolic blood pressure to lower cardiovascular risk.
• Angina pectoris: decreases myocardial oxygen demand, relieving chest pain episodes.
• Myocardial infarction: improves survival and reduces the likelihood of recurrent heart attacks.
• Heart failure: enhances left‑ventricular function and decreases hospitalisation rates.
• Cardiac arrhythmias: controls heart rate in atrial fibrillation and other rhythm disorders.

• Metoprolol Tartrate selectively antagonises β1‑adrenergic receptors in cardiac tissue, blocking the effects of endogenous catecholamines such as norepinephrine. This inhibition reduces heart rate, myocardial contractility, and conduction velocity, leading to decreased cardiac output and lower arterial pressure. By sparing β2 receptors, it minimises bronchial and peripheral vascular effects, providing a targeted cardiovascular response.

Metoprolol Aurobindo may be associated with a range of adverse reactions, which are categorised by frequency and severity.

Common Side Effects

• Fatigue: feeling of tiredness or reduced energy.
• Dizziness: light‑headed sensation, especially on standing.
• Cold extremities: reduced blood flow to hands and feet.
• Gastrointestinal upset: nausea, abdominal discomfort or constipation.

Serious or Rare Side Effects

• Bradycardia: excessively slow heart rate that may require medical attention.
• Hypotension: marked drop in blood pressure leading to fainting.
• Heart block: impaired electrical conduction within the heart.
• Bronchospasm: narrowing of airways, particularly in patients with asthma.

Before prescribing Metoprolol Aurobindo, clinicians should consider several safety factors to minimise risk.

• Assess cardiac function: evaluate baseline heart rate and blood pressure.
• Review respiratory history: use cautiously in patients with asthma or chronic obstructive pulmonary disease.
• Monitor glucose control: beta‑blockers may mask hypoglycaemia symptoms in diabetic patients.
• Consider drug interactions: avoid concurrent use with certain calcium‑channel blockers or anti‑arrhythmics without monitoring.
• Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Metoprolol Aurobindo can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Non‑selective beta‑blockers or other β‑blockers: additive bradycardia and hypotension.
• Certain anti‑arrhythmic agents (e.g., amiodarone, verapamil): may cause severe conduction disturbances.

Moderate Interactions (Monitor Closely)

• Antidiabetic drugs (insulin, sulfonylureas): may mask hypoglycaemia signs.
• NSAIDs or corticosteroids: can reduce antihypertensive effect of metoprolol.